Azka Fatima , Shahid Shah , Akhtar Rasul , Ghulam Abbas , Abid Mahmood , Muhammad Hanif , Alina Ilyas , Maira Tahir , Safirah Maheen , Iqra Mubeen , Tahira Zaheer , Muhammad Abu Sufian , Saleha Babar , Nader I. Namazi
{"title":"Nanoparticles of quercetin-gellan gum conjugate for the controlled delivery of fluconazole","authors":"Azka Fatima , Shahid Shah , Akhtar Rasul , Ghulam Abbas , Abid Mahmood , Muhammad Hanif , Alina Ilyas , Maira Tahir , Safirah Maheen , Iqra Mubeen , Tahira Zaheer , Muhammad Abu Sufian , Saleha Babar , Nader I. Namazi","doi":"10.1016/j.colsurfb.2025.114681","DOIUrl":null,"url":null,"abstract":"<div><div>The aim of the study was to formulate the polymeric nanoparticles for the controlled delivery of fluconazole (FCZ) to enhance its absorption, mucosal adherence, and bioavailability. FCZ-loaded gellan gum-quercetin conjugate (GQC) nanoparticles (FCZ-loaded NGQ) were prepared by ionic gelatin method using GQC, surfactants, co-surfactants, and cross-linker. The nanoparticles were then characterized by various physical and chemical analytical tools such as <sup>1</sup>H NMR, FTIR, XRD, DSC, TGA, particle size, zeta potential, and SEM analysis. All the nanoparticles have a nanosized range from 108 nm to 123 nm with a zeta potential of −12 mV to −20 mV which shows their stability. The NGQ3 (optimized formulation) loaded with FCZ have a PDI of 0.20 ± 0.02 and % entrapment efficiency of 32.3 ± 2.8 %. These studies also showed promising results of 85 % drug release, the value for zero order kinetics of <em>R</em><sup><em>2</em></sup> was 0.999, mucosal adherence of 24 h, and the highest values of permeation was shown by NGQ3 of 60 %. The improved antifungal activity of prepared NGQ3-DL against <em>Candida albicans</em> was observed compared to the pure drug. The nanoparticles may offer enhanced bioavailability and controlled release of FCZ, making them a potential breakthrough in managing FCZ resistant infections.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"252 ","pages":"Article 114681"},"PeriodicalIF":5.4000,"publicationDate":"2025-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Colloids and Surfaces B: Biointerfaces","FirstCategoryId":"1","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0927776525001882","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOPHYSICS","Score":null,"Total":0}
引用次数: 0
Abstract
The aim of the study was to formulate the polymeric nanoparticles for the controlled delivery of fluconazole (FCZ) to enhance its absorption, mucosal adherence, and bioavailability. FCZ-loaded gellan gum-quercetin conjugate (GQC) nanoparticles (FCZ-loaded NGQ) were prepared by ionic gelatin method using GQC, surfactants, co-surfactants, and cross-linker. The nanoparticles were then characterized by various physical and chemical analytical tools such as 1H NMR, FTIR, XRD, DSC, TGA, particle size, zeta potential, and SEM analysis. All the nanoparticles have a nanosized range from 108 nm to 123 nm with a zeta potential of −12 mV to −20 mV which shows their stability. The NGQ3 (optimized formulation) loaded with FCZ have a PDI of 0.20 ± 0.02 and % entrapment efficiency of 32.3 ± 2.8 %. These studies also showed promising results of 85 % drug release, the value for zero order kinetics of R2 was 0.999, mucosal adherence of 24 h, and the highest values of permeation was shown by NGQ3 of 60 %. The improved antifungal activity of prepared NGQ3-DL against Candida albicans was observed compared to the pure drug. The nanoparticles may offer enhanced bioavailability and controlled release of FCZ, making them a potential breakthrough in managing FCZ resistant infections.
期刊介绍:
Colloids and Surfaces B: Biointerfaces is an international journal devoted to fundamental and applied research on colloid and interfacial phenomena in relation to systems of biological origin, having particular relevance to the medical, pharmaceutical, biotechnological, food and cosmetic fields.
Submissions that: (1) deal solely with biological phenomena and do not describe the physico-chemical or colloid-chemical background and/or mechanism of the phenomena, and (2) deal solely with colloid/interfacial phenomena and do not have appropriate biological content or relevance, are outside the scope of the journal and will not be considered for publication.
The journal publishes regular research papers, reviews, short communications and invited perspective articles, called BioInterface Perspectives. The BioInterface Perspective provide researchers the opportunity to review their own work, as well as provide insight into the work of others that inspired and influenced the author. Regular articles should have a maximum total length of 6,000 words. In addition, a (combined) maximum of 8 normal-sized figures and/or tables is allowed (so for instance 3 tables and 5 figures). For multiple-panel figures each set of two panels equates to one figure. Short communications should not exceed half of the above. It is required to give on the article cover page a short statistical summary of the article listing the total number of words and tables/figures.